Navigation Links
Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
Date:4/3/2013

, future developments or otherwise.

Additional Information and Where to Find It

This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of Obagi. Valeant has filed a Tender Offer Statement on Schedule TO with the U.S. Securities and Exchange Commission on March 26, 2013, and Obagi has filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer on March 26, 2013. Valeant expects to file an amendment to the Schedule TO, and Obagi is expected to file an amendment to the Schedule 14D-9 to reflect the new offer price.  Stockholders and other investors are urged to read the tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement, in each case as amended (to the extent applicable), because they contain important information which should be read carefully before any decision is made with respect to the tender offer. The Offer to Purchase, the related Letter of Transmittal and certain other offer documents, as well as the Solicitation/Recommendation Statement, have been made available to all stockholders of Obagi at no expense to them. The Tender Offer Statement and the Solicitation/Recommendation Statement are available for free at the Commission's web site at www.sec.gov. In addition, the tender offer statement and other documents that Valeant files with the SEC are and will be made available to all stockholders of Obagi free of charge at www.valeant.com. The solicitation/recommendation statement and the other documents filed by Obagi with the SEC are and will be made available to all stockholders of Obagi free of charge at www.obagi.com.

Contact Information:

Laurie W. Little
949-461-6002

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Announces Private Exchange Offer
2. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
3. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
4. Valeant Completes Acquisition Of Natur Produkt In Russia
5. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
6. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
7. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
8. Valeant Pharmaceuticals Announces New Management Appointments
9. Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
10. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
11. Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NEW YORK , July 7, 2015 ... Lina Medical ApS has been settled for an undisclosed ... the case was filed in March 2014 in the ... , on behalf of a widower whose wife ... she had undergone a hysterectomy that involved the use ...
(Date:7/7/2015)... , July 7, 2015 According ... by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, ... Academic Research Institute) - Forecast to 2019", published by MarketsandMarkets, ... $3,893.5 Million by 2019 from $2,750.2 Million in 2014 at ... 1 78 ma rket ...
(Date:7/7/2015)... MILAN , July 7, 2015 /PRNewswire/ ... que la société P&R annonce l,acquisition de ... active au niveau mondial, spécialisée dans la ... à base d,acide hyaluronique.      ... est l,un des principaux groupes chimiques et ...
Breaking Medicine Technology:Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4
... Nov. 20 PAREXEL International,Corporation (Nasdaq: ... bio/pharmaceutical services,organization, has appointed Dr. Victor ... Pharmacoepidemiology within the Company,s Clinical Research,Services ... clients in,the design and conduct of ...
... ANTIPOLIS, France, Nov. 20 NicOx S.A. (Eurolist:,COX) today ... in a phase 2 proof of concept study for ... TOPIGEN press release attached.,This new study is expected to ... COPD. TPI 1020 is a new chemical entity and ...
Cached Medicine Technology:PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 2PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 3PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri 4NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 2NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 3NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 4NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 5NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 6NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020 7
(Date:7/7/2015)... ... July 07, 2015 , ... Researchers at UC Davis have ... (or didn’t) and how similar programs can be improved. , Interviewing staff, clinicians ... Community of Practice (HEALTH COP) program, the team identified four factors that helped ...
(Date:7/7/2015)... ... July 07, 2015 , ... sweetFrog ... interact with fans and provide frozen yogurt offerings at Live Nation's amphitheaters in ... will be on site at concerts throughout the summer and brand ambassadors will ...
(Date:7/7/2015)... BELLINGHAM, WA (PRWEB) , ... July 07, 2015 , ... ... set to break ground as early as Summer 2015 on a four-acre site in ... dollar project, with the support of city officials and other members of the local ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... a mark on the cosmetic surgery industry with its commitment, teamwork, and dedication ... VisitandCare.com partnered medical provider is committed to patient safety, world-class results, and compassionate ...
(Date:7/7/2015)... ... 2015 , ... Owners of Green Ladies Cleaning are very pleased to announce ... This honor can only be gained by votes from Madison Magazine readership. , The ... and methods they use daily. Having a home cleaned with all-natural products means that ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3Health News:sweetFrog Mobile Trucks to Offer Froyo at Live Nation Venues 2Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2
... 1 of every 91 children is affected, , MONDAY, Oct. ... the prevalence of autism spectrum disorders in American children was ... estimates that the prevalence is more likely about 1 in ... in the October issue of Pediatrics , estimated that ...
... that many diagnosed with autism have underlying medical disorders ... and clinicians from around the world will discuss current ... Now! Conference in Dallas, TX. , DALLAS, Oct. ... from a 2007 telephone survey in Pediatrics ...
... ... for Life Insurance by KF Financial, Inc. has just launched its ... refreshing break from typical insurance websites with its comprehensive information, up ... Set for Life Insurance is nationally recognized for helping physicians, dentists ...
... gives curry powder its yellow/orange color, may inhibit the adverse ... who continue to smoke. In a paper presented at ... Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San ... neck squamous cell carcinoma (HNSCC) growths. The study used an ...
... on a blood-thinning drug who starts bleeding more than expected, ... thinner and antidote were designed to work together. Researchers at ... this for an entire, versatile class of drugs called aptamers ... "With any anticoagulant, you are trying to reduce your chances ...
... local elder services, report suggests , SUNDAY, Oct. 4 (HealthDay ... look good, they may also be helpful in getting some ... University study suggests. , A survey of 40 stylists ... with their older clients, and these seniors tend to talk ...
Cached Medicine News:Health News:Autism May Be More Common Than Thought 2Health News:Autism May Be More Common Than Thought 3Health News:New Government Research Finds One in Every 100 Children Has Autism, of Whom Nearly 40% Are Recovered 2Health News:New Website for Disability Insurance Launched by Set for Life Insurance by KF Financial 2Health News:Designing drugs and their antidotes together improves patient care 2Health News:Designing drugs and their antidotes together improves patient care 3Health News:Hairstylists Often Privy to Older Clients' Health Issues 2
... athenaCollector™ is athenahealth's ... management solution. It provides ... billing capabilities in the ... claims and billing processes ...
... powder reagent once reconstituted offers the laboratory ... to help maximize laboratory productivity, minimize operator ... The proprietary technology of the Infinity Uric ... life and stability once reconstituted that will ...
... The Infinity Triglycerides single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Triglycerides reagent provides a ...
... Hexokinase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Hexokinase reagent provides a long shelf ...
Medicine Products: